Based on our corporate philosophy of "Contributing to the health of humankind through the development of revolutionary biotechnologies such as gene therapy," As a " We aim to be a global platformer that is responsible for the infrastructure of the life science industry through our Reagents/Instruments and CDMO businesses." We provide products and services to universities, government agencies, pharmaceutical companies, and others in the businesses of Reagents/Instruments, CDMO and Gene Therapy. We also provide economic and social value to stakeholders through the development of diverse talent and the reduction of environmental impacts. We will continue to circulate this value creation process and contribute to the sustainable improvement of corporate value.
